| R2WA Stock | | | EUR 0.41 0.00 0.00% |
BEXIMCO PHARMAGDR market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for BEXIMCO PHARMAGDR REGS or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also
Equity Screeners to view more equity screening tools
BEXIMCO PHARMAGDR REGS has current Market Risk Adjusted Performance of 35.15.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 35.15 | |
| ER[a] | = | Expected return on investing in BEXIMCO PHARMAGDR |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
BEXIMCO PHARMAGDR Market Risk Adjusted Performance Peers Comparison
BEXIMCO Market Risk Adjusted Performance Relative To Other Indicators
BEXIMCO PHARMAGDR REGS is rated
third in market risk adjusted performance category among its peers. It is rated
second in maximum drawdown category among its peers reporting about
0.91 of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Market Risk Adjusted Performance to Maximum Drawdown for BEXIMCO PHARMAGDR REGS is roughly
1.09
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.